ARCHIVES

Special Issue: Broder Resigns NCI To Take Job With Drug Company IVAX

This article is from The Cancer Letter archive.

Vol. 20 No. 49 | December 22, 1994

Download PDF Visit The Full Archive

Related Articles

Severe Shortages Of Many Cancer Drugs Affecting Practices

November 19, 2010

In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List

December 2, 1983

FDA To Issue “Complete Response” Letters To Drug Sponsors.

July 11, 2008

CDC: Lung Cancer Rates Drop Following Anti-Smoking Efforts

January 17, 2014

NCI To Cut Smoking Intervention Study By 20%, Says Chemoprevention Accrual Has Priority

November 6, 1992

ODAC Rejects Temodal for Melanoma After Discussion Of Approval Standards

April 2, 1999